scorecardresearch
Add as a preferred source on Google
Sunday, March 15, 2026
TopicCadila Healthcare

Topic: Cadila Healthcare

Cadila looks to double its vaccine production as India battles to contain second Covid wave

The Indian drugmaker expects regulatory approval for its vaccine against Covid-19 by June. Efficacy readings from its last stage of clinical trials are expected in May.

Cadila to boost Covid vaccine production capacity by 70% if it passes human trials

Cadila is looking to hire contract manufacturers for additional 50-70 million doses of its vaccine, on top of 100 million that will come from its own capacity.

Kraft Heinz to sell some of its Indian businesses to Zydus for Rs 46 billion

Kraft to sell Complan, Glucon D & Nycil, among others to Zydus Wellness, in a deal estimated to be worth $625 million.

On Camera

Gulf conflict pushes Dubai diamond traders to eye Surat for rough stone auctions. But there are hurdles

Industry leaders say India’s complicated customs process and GST levies are deterrents for traders to come to Surat for auctions.

Supreme Leader Mojtaba, the man Iran must keep alive & the secret force ‘tasked with it’—all about NOPO

The Nirouyeh Vijeh Pasdaran Velayat, or NOPO, was the only force Ali Khamenei trusted.It was founded in 1991 and is more feared than the Revolutionary Guards.

Peaceful power transfers followed uprisings in India’s neighbourhood. It’s a sign of mature democracies

Rating democracies is a tricky business. I am only using the simple metric of who in the Indian subcontinent has had the most peaceful, stable, normal political transitions and continuity.